- Home
- ANGO vs EIC Comparison
ANGO vs EIC Comparison
Compare ANGO & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- EIC
- Stock Information
- Founded
- ANGO 1988
- EIC N/A
- Country
- ANGO United States
- EIC United States
- Employees
- ANGO N/A
- EIC N/A
- Industry
- ANGO Medical/Dental Instruments
- EIC Finance/Investors Services
- Sector
- ANGO Health Care
- EIC Finance
- Exchange
- ANGO Nasdaq
- EIC Nasdaq
- Market Cap
- ANGO 439.5M
- EIC 355.7M
- IPO Year
- ANGO 2004
- EIC 2019
- Fundamental
- Price
- ANGO $9.28
- EIC $14.36
- Analyst Decision
- ANGO Strong Buy
- EIC Strong Buy
- Analyst Count
- ANGO 2
- EIC 1
- Target Price
- ANGO $14.00
- EIC $17.50
- AVG Volume (30 Days)
- ANGO 330.5K
- EIC 186.3K
- Earning Date
- ANGO 04-02-2025
- EIC 05-20-2025
- Dividend Yield
- ANGO N/A
- EIC 16.67%
- EPS Growth
- ANGO N/A
- EIC N/A
- EPS
- ANGO N/A
- EIC 1.97
- Revenue
- ANGO $283,320,000.00
- EIC $46,223,036.00
- Revenue This Year
- ANGO N/A
- EIC $39.61
- Revenue Next Year
- ANGO $6.35
- EIC $27.28
- P/E Ratio
- ANGO N/A
- EIC $7.33
- Revenue Growth
- ANGO N/A
- EIC 72.79
- 52 Week Low
- ANGO $5.47
- EIC $12.73
- 52 Week High
- ANGO $13.50
- EIC $16.71
- Technical
- Relative Strength Index (RSI)
- ANGO 48.87
- EIC 50.89
- Support Level
- ANGO $8.55
- EIC $13.82
- Resistance Level
- ANGO $9.61
- EIC $14.67
- Average True Range (ATR)
- ANGO 0.36
- EIC 0.22
- MACD
- ANGO -0.04
- EIC 0.11
- Stochastic Oscillator
- ANGO 60.33
- EIC 72.07
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.